SCHEMBL29566980

SCHEMBL29566980

Cc1ccccc1-c1nc(NS(=O)(=O)c2cnn(C)c2)nc(Oc2cccc(N3CCN(C)CC3)c2)c1C(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 2/20 0.40
▸ HTR7 P34969 2/20 0.40
▸ HTR2A P28223 1/20 0.40
▸ HTR2C P28335 1/20 0.40
▸ DRD3 P35462 1/20 0.40
▸ HTR6 P50406 1/20 0.40
▸ RAD52 P43351 2/20 0.38
▸ BRD4 O60885 6/20 0.36
▸ GUSB P08236 1/20 0.35
▸ CTSC P53634 2/20 0.35
▸ JAK2 O60674 6/20 0.35
▸ JAK3 P52333 4/20 0.34
▸ JAK1 P23458 2/20 0.34
▸ BRD2 P25440 2/20 0.34
▸ BRD3 Q15059 2/20 0.34
▸ BRDT Q58F21 2/20 0.34
▸ EGFR P00533 2/20 0.34
▸ PTK2 Q05397 1/20 0.34
▸ BUB1B O60566 1/20 0.34
▸ RET P07949 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310151 1.00 HTR1A (0.40) HTR1AHTR7HTR2AHTR2CDRD3
SCHEMBL24309842 0.93 CTSC (0.39) HTR1AHTR7HTR2AHTR2CDRD3
SCHEMBL29566851 0.92 RAD52 (0.38) HTR1AHTR7HTR2AHTR2CDRD3
SCHEMBL24310157 0.92 RAD52 (0.38) HTR1AHTR7HTR2AHTR2CDRD3
SCHEMBL29566715 0.92 HTR1A (0.38) HTR1AHTR7HTR2AHTR2CDRD3
SCHEMBL24310777 0.92 HTR1A (0.38) HTR1AHTR7HTR2AHTR2CDRD3
SCHEMBL29567219 0.91 HTR7 (0.42) HTR1AHTR7HTR2AHTR2CDRD3
SCHEMBL24309381 0.91 HTR7 (0.42) HTR1AHTR7HTR2AHTR2CDRD3
SCHEMBL24310431 0.89 HTR2C (0.41) HTR1AHTR7HTR2AHTR2CDRD3
SCHEMBL29566298 0.89 HTR2C (0.41) HTR1AHTR7HTR2AHTR2CDRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback